Synthetic Biology Platforms
Ginkgo Bioworks
by Ginkgo Bioworks Holdings, Inc.
The organism engineering platform making biology easier to engineer
Category
Synthetic Biology Platforms
Founded
2008
Headquarters
Boston, MA, USA
Overview
Ginkgo Bioworks operates the world's largest platform for programming cells, offering automated foundry services for organism design, build, and testing. The platform combines high-throughput strain engineering, fermentation optimization, and AI-guided design to help customers develop biological products across pharmaceuticals, agriculture, food, fragrances, and industrial chemicals. Biotech companies, agricultural firms, and industrial manufacturers partner with Ginkgo to engineer organisms for specific applications — from producing novel enzymes and flavors to manufacturing pharmaceutical intermediates. Ginkgo's Foundry has executed over 170 cell programs for more than 100 customers, leveraging a codebase of biological parts and proprietary genetic design tools. Ginkgo's scale is its primary differentiator — the company has invested over $1 billion in foundry infrastructure, maintains one of the largest proprietary libraries of engineered organisms, and operates at a throughput that would be impossible for individual biotech companies. The acquisition of Zymergen's assets further expanded its capabilities in materials science and computational biology.
Key Features
Biosecurity Screening
Automated screening of synthetic DNA orders against regulated pathogen sequences.
Metabolic Modeling
Genome-scale metabolic models predict optimal genetic modifications for target compound production.
Cell-Free Prototyping
Rapid testing of genetic designs in cell-free systems before committing to cellular construction.
Fermentation Optimization
Data-driven optimization of fermentation conditions from lab-scale to commercial biomanufacturing.
Foundry-Scale Assembly
Robotic DNA assembly and transformation processing thousands of genetic designs in parallel.
Pros & Cons
Pros
- +Foundry-scale automation processes thousands of genetic designs in parallel
- +Cell programming platform designs custom organisms for therapeutics, agriculture, and industrial biotechnology
- +Automated organism engineering combines high-throughput strain construction with ML-guided design
- +End-to-end platform from DNA design through fermentation optimization and process development
- +Metabolic modeling predicts optimal genetic modifications for target compound production
- +Proprietary strain libraries and genetic parts catalogs accelerate design-build-test-learn cycles
Cons
- −Regulatory frameworks for engineered organisms vary globally and can delay commercialization
- −Scale-up from laboratory to commercial production introduces unpredictable biological challenges
- −Design-build-test-learn cycles still require weeks to months for complex organism engineering
- −High upfront investment in foundry automation infrastructure before generating meaningful results
- −Intellectual property landscape for genetic parts and engineered organisms is complex
Use Cases
Strain Engineering & Optimization
Automated organism engineering combining high-throughput strain construction with ML-guided metabolic design.
Biosynthetic Pathway Design
Computational design of metabolic pathways for production of target compounds in engineered organisms.
Fermentation Scale-Up
Data-driven optimization of fermentation conditions from lab-scale to commercial biomanufacturing.